175 related articles for article (PubMed ID: 32715405)
21. The use of biomarkers for the etiologic diagnosis of MCI in Europe: an EADC survey.
Bocchetta M; Galluzzi S; Kehoe PG; Aguera E; Bernabei R; Bullock R; Ceccaldi M; Dartigues JF; de Mendonça A; Didic M; Eriksdotter M; Félician O; Frölich L; Gertz HJ; Hallikainen M; Hasselbalch SG; Hausner L; Heuser I; Jessen F; Jones RW; Kurz A; Lawlor B; Lleo A; Martinez-Lage P; Mecocci P; Mehrabian S; Monsch A; Nobili F; Nordberg A; Rikkert MO; Orgogozo JM; Pasquier F; Peters O; Salmon E; Sánchez-Castellano C; Santana I; Sarazin M; Traykov L; Tsolaki M; Visser PJ; Wallin ÅK; Wilcock G; Wilkinson D; Wolf H; Yener G; Zekry D; Frisoni GB
Alzheimers Dement; 2015 Feb; 11(2):195-206.e1. PubMed ID: 25150733
[TBL] [Abstract][Full Text] [Related]
22. Clinical utility and applicability of biomarker-based diagnostic criteria for Alzheimer's disease: a BeDeCo survey.
Bier JC; Verschraegen J; Vandenberghe R; Guillaume B; Picard G; Otte G; Mormont E; Gilles C; Segers K; Sieben A; Thiery E; Ventura M; De Deyn P; Deryck O; Versijpt J; Salmon E; Engelborghs S; Ivanoiu A
Acta Neurol Belg; 2015 Dec; 115(4):547-55. PubMed ID: 25576445
[TBL] [Abstract][Full Text] [Related]
23. Estimating Alzheimer's Disease Progression Rates from Normal Cognition Through Mild Cognitive Impairment and Stages of Dementia.
Davis M; O Connell T; Johnson S; Cline S; Merikle E; Martenyi F; Simpson K
Curr Alzheimer Res; 2018; 15(8):777-788. PubMed ID: 29357799
[TBL] [Abstract][Full Text] [Related]
24. Incremental value of biomarker combinations to predict progression of mild cognitive impairment to Alzheimer's dementia.
Frölich L; Peters O; Lewczuk P; Gruber O; Teipel SJ; Gertz HJ; Jahn H; Jessen F; Kurz A; Luckhaus C; Hüll M; Pantel J; Reischies FM; Schröder J; Wagner M; Rienhoff O; Wolf S; Bauer C; Schuchhardt J; Heuser I; Rüther E; Henn F; Maier W; Wiltfang J; Kornhuber J
Alzheimers Res Ther; 2017 Oct; 9(1):84. PubMed ID: 29017593
[TBL] [Abstract][Full Text] [Related]
25. [Early detection of Alzheimer's disease and dementia prediction in patients with mild cognitive impairment : Summary of current recommendations].
Rostamzadeh A; Jessen F
Nervenarzt; 2020 Sep; 91(9):832-842. PubMed ID: 32300816
[TBL] [Abstract][Full Text] [Related]
26. [Review of recommendations and new diagnosis criteria for mild cognitive impairment due to Alzheimer's disease].
Allegri RF; Russo MJ; Kremer J; Taragano FE; Brusco I; Ollari JA; Serrano CM; Sarasola D; Demey I; Arizaga RL; Bagnati P
Vertex; 2012; 23(101):5-15. PubMed ID: 22880190
[TBL] [Abstract][Full Text] [Related]
27. New diagnostic criteria for Alzheimer's disease and mild cognitive impairment for the practical neurologist.
Budson AE; Solomon PR
Pract Neurol; 2012 Apr; 12(2):88-96. PubMed ID: 22450454
[TBL] [Abstract][Full Text] [Related]
28. Neuropsychiatric symptoms differently affect mild cognitive impairment and Alzheimer's disease patients: a retrospective observational study.
Scaricamazza E; Colonna I; Sancesario GM; Assogna F; Orfei MD; Franchini F; Sancesario G; Mercuri NB; Liguori C
Neurol Sci; 2019 Jul; 40(7):1377-1382. PubMed ID: 30903419
[TBL] [Abstract][Full Text] [Related]
29. Metabolic Profiles Help Discriminate Mild Cognitive Impairment from Dementia Stage in Alzheimer's Disease.
Jääskeläinen O; Hall A; Tiainen M; van Gils M; Lötjönen J; Kangas AJ; Helisalmi S; Pikkarainen M; Hallikainen M; Koivisto A; Hartikainen P; Hiltunen M; Ala-Korpela M; Soininen P; Soininen H; Herukka SK
J Alzheimers Dis; 2020; 74(1):277-286. PubMed ID: 32007958
[TBL] [Abstract][Full Text] [Related]
30. New criteria for Alzheimer disease and mild cognitive impairment: implications for the practicing clinician.
Budson AE; Solomon PR
Neurologist; 2012 Nov; 18(6):356-63. PubMed ID: 23114667
[TBL] [Abstract][Full Text] [Related]
31. Diagnostic differentiation of mild cognitive impairment due to Alzheimer's disease using a hippocampus-dependent test of spatial memory.
Moodley K; Minati L; Contarino V; Prioni S; Wood R; Cooper R; D'Incerti L; Tagliavini F; Chan D
Hippocampus; 2015 Aug; 25(8):939-51. PubMed ID: 25605659
[TBL] [Abstract][Full Text] [Related]
32. 18F-FDG PET diagnostic and prognostic patterns do not overlap in Alzheimer's disease (AD) patients at the mild cognitive impairment (MCI) stage.
Morbelli S; Bauckneht M; Arnaldi D; Picco A; Pardini M; Brugnolo A; Buschiazzo A; Pagani M; Girtler N; Nieri A; Chincarini A; De Carli F; Sambuceti G; Nobili F
Eur J Nucl Med Mol Imaging; 2017 Nov; 44(12):2073-2083. PubMed ID: 28785843
[TBL] [Abstract][Full Text] [Related]
33. Neuropsychological Contribution to Predict Conversion to Dementia in Patients with Mild Cognitive Impairment Due to Alzheimer's Disease.
Silva D; Cardoso S; Guerreiro M; Maroco J; Mendes T; Alves L; Nogueira J; Baldeiras I; Santana I; de Mendonça A
J Alzheimers Dis; 2020; 74(3):785-796. PubMed ID: 32083585
[TBL] [Abstract][Full Text] [Related]
34. Mild cognitive impairment has similar alterations as Alzheimer's disease in gut microbiota.
Li B; He Y; Ma J; Huang P; Du J; Cao L; Wang Y; Xiao Q; Tang H; Chen S
Alzheimers Dement; 2019 Oct; 15(10):1357-1366. PubMed ID: 31434623
[TBL] [Abstract][Full Text] [Related]
35. Early differentiation of dementia with Lewy bodies and Alzheimer's disease: Heart rate variability at mild cognitive impairment stage.
Kim MS; Yoon JH; Hong JM
Clin Neurophysiol; 2018 Aug; 129(8):1570-1578. PubMed ID: 29883835
[TBL] [Abstract][Full Text] [Related]
36. Erlangen Score as a tool to predict progression from mild cognitive impairment to dementia in Alzheimer's disease.
Baldeiras I; Santana I; Leitão MJ; Vieira D; Duro D; Mroczko B; Kornhuber J; Lewczuk P
Alzheimers Res Ther; 2019 Jan; 11(1):2. PubMed ID: 30611311
[TBL] [Abstract][Full Text] [Related]
37. What Belgian geriatricians tell their patients with Alzheimer's disease and why: a national survey.
Segers K
Acta Neurol Belg; 2009 Dec; 109(4):283-93. PubMed ID: 20120208
[TBL] [Abstract][Full Text] [Related]
38. Attitudes of elderly subjects toward "truth telling" for the diagnosis of Alzheimer's disease.
Turnbull Q; Wolf AM; Holroyd S
J Geriatr Psychiatry Neurol; 2003 Jun; 16(2):90-3. PubMed ID: 12801158
[TBL] [Abstract][Full Text] [Related]
39. Mild cognitive impairment: an update in Parkinson's disease and lessons learned from Alzheimer's disease.
Goldman JG; Aggarwal NT; Schroeder CD
Neurodegener Dis Manag; 2015 Oct; 5(5):425-43. PubMed ID: 26517759
[TBL] [Abstract][Full Text] [Related]
40. Role of cerebrospinal fluid biomarkers to predict conversion to dementia in patients with mild cognitive impairment: a clinical cohort study.
Tondelli M; Bedin R; Chiari A; Molinari MA; Bonifacio G; Lelli N; Trenti T; Nichelli P
Clin Chem Lab Med; 2015 Feb; 53(3):453-60. PubMed ID: 25274948
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
